Following the failure of Meadows in qualifying for the finals in Daegu, questions are being raised if she is fit to compete in races. It has been informed that the semifinal or qualifying match she stood third and lost the opportunity of taking part in the finals.
Meadows defeat is counted as the worst defeat as she finished 200 meter track in 1:59.07 minute. While defending her performance at the semifinal, Meadows said that she gave her 98% and her 2% efforts failed her.
She further said that defeat at Daegu has not dither her moral from taking part in the matches. Now, she is working harder to improve her performance. Her defeat at Daegu has shocked the world as in her training sessions she has been doing magnificently better.
Accepting her defeat, Meadows promised the world that she will turn stronger and will make a new comeback. The defeat has undoubtedly hurt her as she said that the two nights of her life will be toughest as she will be mere spectator of the race.
Two years back, Meadow’s efforts made her win a bronze medal in Berlin where Bolt of Jamaica made the record and became the fastest man of the world.
According to a post published to Microsoft’s official blog on Wednesday, the number of devices running the company’s latest Windows version — the Windows 10 operating system — has touched 350 million.
The new milestone in the Windows 10…
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies…
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle…
The Verge has revealed in a Wednesday report, citing a statement released by Lexus, that the working of the head units of a number of vehicles has been affected because of an over-the-air (OTA) update recently rolled out by the company.
…
The drought conditions in California is widening economic split in California. The prospect of…
Tech giant Google posted a video of a developer presentation to the Google Developers YouTube…
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won’t seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said…
In a Tuesday announcement, Adobe revealed that it has...
With the computer business having witnessed steep losses...
In a scenario where the government of the nations are...
After the event that was the 'hot-news' of the week, the...
© 2024 AustrianTribune